Turner Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-400
Closed -$58K 83
2017
Q3
$58K Sell
400
-1,740
-81% -$237K 0.26% 75
2017
Q2
$278K Sell
2,140
-3,200
-60% -$392K 0.18% 153
2017
Q1
$664K Buy
5,340
+3,110
+139% +$372K 0.43% 86
2016
Q4
$258K Sell
2,230
-3,380
-60% -$376K 0.1% 212
2016
Q3
$586K Sell
5,610
-2,140
-28% -$232K 0.19% 138
2016
Q2
$764K Buy
7,750
+2,550
+49% +$264K 0.24% 117
2016
Q1
$520K Sell
5,200
-6,000
-54% -$618K 0.14% 155
2015
Q4
$1.34M Sell
11,200
-1,890
-14% -$219K 0.28% 106
2015
Q3
$1.42M Buy
+13,090
New +$1.62M 0.29% 109
2015
Q2
Sell
-14,560
Closed -$1.68M 471
2015
Q1
$1.68M Sell
14,560
-1,591
-10% -$190K 0.3% 106
2014
Q4
$1.81M Buy
16,151
+102
+0.6% +$10.8K 0.21% 161
2014
Q3
$1.52M Buy
+16,049
New +$1.45M 0.09% 306

Other funds holding CELG

Turner Investments's CELG Position: Q4 2017 in Review

Turner Investments sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 400 shares — an estimated $58K sold.

Turner Investments first reported a position in CELG in Q3 2014 and held it in 12 quarters. The position peaked at $1.81M in Q4 2014. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Turner Investments reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Turner Investments sold 400 Celgene Corp shares in Q4 2017, an estimated $58K.
  • Turner Investments first reported a position in Celgene Corp in Q3 2014 and held it in 12 quarters.
  • Turner Investments's Celgene Corp position peaked at $1.81M in Q4 2014.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Turner Investments's 13F filing for Q4 2017, filed 2 Feb 2018.